The Biostation Semaglutide Review

The Biostation is a substantial regional wellness chain with an unusually broad footprint. Our research (August 8, 2026) found nine locations and a service framing that mixes medicine with the wellness register.

A Wide Footprint

Locations span East Delray Beach, West Delray Beach, Midtown Miami, The Boca Raton, Carillon Miami Wellness Resort, Midtown Tampa, Grand Wailea, Jacksonville and St. Petersburg, plus Telehealth & Remote Care. That is nine physical sites across Florida with one in Hawaii, several of them inside luxury resort properties — Carillon Miami Wellness Resort, The Boca Raton and Grand Wailea. The resort placements tell you something about the intended clientele and, by implication, the pricing tier. Offering telehealth alongside physical locations is sensible, letting existing patients maintain care between visits.

The "GLP-1 Peptide" Framing

The practice describes its offering as "GLP-1 peptide weight loss." This is technically defensible and worth unpacking. Semaglutide is a peptide — a modified analogue of the naturally occurring GLP-1 hormone — so calling it a peptide is not wrong. But in the wellness market "peptide therapy" is a category with a very different evidence profile, covering compounds like sermorelin, BPC-157 and CJC-1295 whose marketing claims consistently exceed published human evidence. We have flagged that category at several practices in this comparison. Grouping semaglutide — which has large randomised trials behind it — under the same "peptide" banner as compounds that do not blurs a distinction patients need. Semaglutide's evidence does not transfer to the rest of a peptide menu.

Supplements Alongside

The practice sells pharmaceutical-grade supplements alongside its medical services. "Pharmaceutical grade" is a marketing term rather than a regulatory category — supplements are not FDA-approved regardless of how they are described — and supplement sales attached to a medical practice are a margin business that should be evaluated separately from the prescription care.

Consultation Process

The practice requests a confidential consultation with a preferred location selected at booking, which is a straightforward entry point.

What Is Not Published

No pricing for semaglutide or any service. No statement of whether the semaglutide is brand-name or compounded — and the "peptide" framing makes compounded more likely, but the practice does not say. No named pharmacy, no 503A/503B status. No published BMI or eligibility criteria, no clinician credentials, no dosing protocol and no monitoring schedule. For a chain of this size operating in premium locations, that is a considerable amount left unsaid.